These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2303316)

  • 21. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte function.
    Elitsur Y; Mutchnick MG; Sakr WA; Luk GD
    Immunopharmacology; 1990; 20(2):89-96. PubMed ID: 2266003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of action of thymosin. II. Effects of aspirin and thymosin on enhancement of IL-2 production.
    Zatz MM; Skotnicki A; Bailey JM; Oliver JH; Goldstein AL
    Immunopharmacology; 1985 Jun; 9(3):189-98. PubMed ID: 3926716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of endogenous prostaglandins by thymosin-alpha 1 in lymphocytes.
    Rinaldi-Garaci C; Garaci E; Del Gobbo V; Favalli C; Jezzi T; Goldstein AL
    Cell Immunol; 1983 Aug; 80(1):57-65. PubMed ID: 6575878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy with natural interleukins and/or thymosin alpha 1 potently augments T-lymphocyte responses of hydrocortisone-treated aged mice.
    Hadden JW; Saha A; Sosa M; Hadden EM
    Int J Immunopharmacol; 1995 Oct; 17(10):821-8. PubMed ID: 8707447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
    Sztein MB; Cuna WR; Kierszenbaum F
    J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymosin alpha 1 enhances haemopoietic colony formation by stimulating the production of interleukin 3 in nu/nu mice.
    Ohta Y; Tamura S; Nihira S; Tezuka E; Imai S; Yagi Y
    Int J Immunopharmacol; 1986; 8(7):773-9. PubMed ID: 3491057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 5 up-regulates high-affinity interleukin 2 receptor expression by human resting peripheral T cells: a comparison with the effect of interleukin 4 on B cells.
    Hara M; Kitani A; Harigai M; Hirose T; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Kawagoe M
    Cytokine; 1991 Nov; 3(6):584-92. PubMed ID: 1790306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S; Kierszenbaum F
    J Immunol; 1996 May; 156(10):3866-74. PubMed ID: 8621925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
    Wolf GT; Peterson KA; Lovett EJ
    Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of two thymosin fraction 5 polypeptides on human peripheral blood lymphocytes.
    Kokkinopoulos D; Perez S; Baxevanis C; Papamichail M
    Immunopharmacol Immunotoxicol; 1987; 9(4):409-19. PubMed ID: 2893819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconstitution of T cell functions in aging mice by thymosin alpha 1.
    Frasca D; Adorini L; Mancini C; Doria G
    Immunopharmacology; 1986 Jun; 11(3):155-63. PubMed ID: 2942521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired expression of high affinity interleukin 2 receptor on activated lymphocytes from patients with systemic lupus erythematosus.
    Ishida H; Kumagai S; Umehara H; Sano H; Tagaya Y; Yodoi J; Imura H
    J Immunol; 1987 Aug; 139(4):1070-4. PubMed ID: 3112222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of interleukin-2 and apha-chain interleukin-2 receptor biosynthesis by cisplatin in human peripheral lymphocytes.
    Sfikakis PP; Souliotis VL; Katsilambros N; Markakis K; Vaiopoulos G; Tsokos GC; Panayiotidis P
    Clin Immunol Immunopathol; 1996 Apr; 79(1):43-9. PubMed ID: 8612350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of age on the human high affinity interleukin 2 receptor of phytohaemagglutinin stimulated peripheral blood lymphocytes.
    Nagel JE; Chopra RK; Powers DC; Adler WH
    Clin Exp Immunol; 1989 Feb; 75(2):286-91. PubMed ID: 2784739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phorbol myristate acetate on T cell colony formation, interleukin-2 (IL-2) receptor expression and IL-2 production by cells from patients at all stages of HIV infection.
    Allouche M; Lunardi-Iskandar Y; Varela-Millot C; Itzhaki M; Cornuet P; Meyer P; Jasmin C; Georgoulias V
    Clin Exp Immunol; 1990 Aug; 81(2):200-6. PubMed ID: 1696861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of bovine herpesvirus-1 on expression of interleukin-2 receptors and effect of interleukin-12 on lymphocyte proliferation.
    Lan HC; Chambers MA; Ferguson JA; Srivastava KK; Reddy PG
    Vet Microbiol; 1996 Mar; 49(1-2):59-66. PubMed ID: 8861643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human thymocytes do not respond to interleukin-2 after removal of mature "bright" CD5 positive cells.
    Ueno Y; Hays EF; Hultin L; Uittenbogaart CH
    Cell Immunol; 1989 Dec; 124(2):239-51. PubMed ID: 2479484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-kB-like factor(s) in cultured human T lymphocytes.
    Brini AT; Harel-Bellan A; Farrar WL
    Eur Cytokine Netw; 1990; 1(3):131-9. PubMed ID: 2129797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor.
    Elliott LH; Brooks WH; Roszman TL
    J Neurooncol; 1992 Sep; 14(1):1-7. PubMed ID: 1335042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.